We invite you to discover Human Gene Therapy Clinical Development, a peer-reviewed journal publishing preclinical research and clinical trial data for gene and cell therapies.

Publication 4/01/2000

Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors.

Xiao W, Chirmule N, Schnell MA, Tazelaar J, Hughes JV, Wilson JM

Molecular Therapy : The Journal Of The American Society Of Gene Therapy

Publication 3/20/2000

Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors.

Stedman H, Wilson JM, Finke R, Kleckner AL, Mendell J

Human Gene Therapy

Publication 3/01/2000

Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle.

Chirmule N, Xiao W, Truneh A, Schnell MA, Hughes JV, Zoltick P, Wilson JM

Journal Of Virology

Publication 3/01/2000

Interferon-gamma-independent CD8+ T cell-mediated protective anti-malaria immunity elicited by recombinant adenovirus.

Rodrigues EG, Claassen J, Lee S, Wilson JM, Nussenzweig RS, Tsuji M

Parasite Immunology

Publication 3/01/2000

Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract.

Lysenko ES, Gould J, Bals R, Wilson JM, Weiser JN

Infection And Immunity

Publication 2/01/2000

Intravenous injection of an adenovirus encoding hepatocyte growth factor results in liver growth and has a protective effect against apoptosis.

Phaneuf D, Chen SJ, Wilson JM

Molecular Medicine